Market Size of Neurofeedback Systems Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 1.30 Billion |
Market Size (2029) | USD 1.9 Billion |
CAGR (2024 - 2029) | 7.72 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Neurofeedback Systems Market Analysis
The Neurofeedback Systems Market size is estimated at USD 1.30 billion in 2024, and is expected to reach USD 1.9 billion by 2029, growing at a CAGR of 7.72% during the forecast period (2024-2029).
During the COVID-19 pandemic, the mental state of individuals was significantly affected, and consequently, many suffered from different psychiatric and neuropsychiatric disorders. For instance, according to the WHO update, in March 2022, in the first year of the COVID-19 pandemic, the global prevalence of anxiety and depression increased by 25%. Furthermore, according to an article published by Einstein in April 2022, the harmful effect of the pandemic on mental health not only existed during the pandemic but also in the post-pandemic era. These neurological manifestations of post-COVID complications were treated by rehabilitation, oxygen therapy, and immunotherapy, and that significantly reduced anxiety and depression. Besides, the COVID-19 pandemic provided an opportunity to develop innovative methods to address the global burden of the increasing number of neurological manifestations. For instance, according to an article published by PLoS One, in July 2022, neurofeedback was feasible for the treatment of post-COVID neurological complications as well as for studying their inter-relatedness. Hence, the COVID-19 pandemic had a significant impact on the market growth.
The increasing burden of brain dysfunctions and increasing technological advancements towards brain monitoring are the factors that drive market growth. For instance, according to the WHO update, in September 2022, more than 55 million people were living with dementia worldwide, and there are nearly 10 million new cases every year. It also stated that Alzheimer's disease is the most common form of dementia and may contribute to 60%-70% of the cases. Furthermore, according to an article published by Global Burden of Diseases, Injuries, and Risk Factors, in January 2022, the number of people with dementia worldwide are likely to increase by 166%, from about 57.4 million in 2019 to 152.8 million people by 2050. Therefore, the increasing prevalence of such brain dysfunction across the global population is expected to drive market growth over the forecast period.
Besides, various technological advancements and innovative product launches in this domain also boost market growth. For instance, in October 2021, Interaxon Inc. launched the second generation of its popular EEG meditation and sleep headband, Muse S. This updated plush brain-sensing headband uses real-time neurofeedback to help learn the art of meditation for falling asleep. Such development is expected to drive market growth over the forecast period.
Hence, the neurofeedback systems market is anticipated to grow due to the abovementioned factors over the forecast period. However, high costs and time-consuming processes will likely restrain the market growth.
Neurofeedback Systems Industry Segmentation
As per the scope of the report, medical professionals use neurofeedback systems to measure and train the human mind to understand their physiological processes to enhance the health and lifestyle of diseases patients. Neurofeedback Systems Market is Segmented by Application (Attention Deficit Hyperactivity Disorder (ADHD), Pain Management, Insomnia, Anxiety Disorder, and Other Applications) and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values (in USD) for the above segments.
By Application | |
Attention Deficit Hyperactivity Disorder (ADHD) | |
Pain Management | |
Insomnia | |
Anxiety Disorder | |
Other Applications |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Neurofeedback Systems Market Size Summary
The neurofeedback systems market is poised for significant growth, driven by the increasing prevalence of brain dysfunctions and advancements in brain monitoring technologies. The COVID-19 pandemic has notably impacted the market, as it heightened the global burden of psychiatric and neuropsychiatric disorders, leading to a surge in demand for innovative treatment methods like neurofeedback. The rising incidence of conditions such as dementia and Alzheimer's disease, coupled with the growing focus on research and development in neurofeedback therapies, is expected to further propel market expansion. Technological innovations, such as the launch of advanced EEG meditation and sleep headbands, also contribute to the market's upward trajectory. However, challenges such as high costs and time-consuming processes may pose constraints to market growth.
North America is anticipated to be a key region for market growth, largely due to the increasing prevalence of target diseases and strategic initiatives aimed at enhancing neurofeedback system adoption. The aging population in this region, particularly those at risk of Alzheimer's disease, is expected to drive demand for neurofeedback systems. The competitive landscape of the market is moderately competitive, with both global and regional players like Brainmaster Technologies Inc., Mind Media, and NeuroCare Group GmbH holding significant market shares. Collaborative efforts and strategic partnerships, such as those between Divergence NeuroTechnologies and OVID Clinics GmbH, are also expected to foster market development. Overall, the neurofeedback systems market is set to experience robust growth, supported by a combination of technological advancements, increasing disease prevalence, and strategic market initiatives.
Neurofeedback Systems Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Burden of Brain Disorders
-
1.2.2 Increasing Technological Advancements Towards Brain Monitoring
-
-
1.3 Market Restraints
-
1.3.1 High-Cost and Time-Consuming Neurofeedback Sessions
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Application
-
2.1.1 Attention Deficit Hyperactivity Disorder (ADHD)
-
2.1.2 Pain Management
-
2.1.3 Insomnia
-
2.1.4 Anxiety Disorder
-
2.1.5 Other Applications
-
-
2.2 Geography
-
2.2.1 North America
-
2.2.1.1 United States
-
2.2.1.2 Canada
-
2.2.1.3 Mexico
-
-
2.2.2 Europe
-
2.2.2.1 Germany
-
2.2.2.2 United Kingdom
-
2.2.2.3 France
-
2.2.2.4 Italy
-
2.2.2.5 Spain
-
2.2.2.6 Rest of Europe
-
-
2.2.3 Asia-Pacific
-
2.2.3.1 China
-
2.2.3.2 Japan
-
2.2.3.3 India
-
2.2.3.4 Australia
-
2.2.3.5 South Korea
-
2.2.3.6 Rest of Asia-Pacific
-
-
2.2.4 Middle East and Africa
-
2.2.4.1 GCC
-
2.2.4.2 South Africa
-
2.2.4.3 Rest of Middle East and Africa
-
-
2.2.5 South America
-
2.2.5.1 Brazil
-
2.2.5.2 Argentina
-
2.2.5.3 Rest of South America
-
-
-
Neurofeedback Systems Market Size FAQs
How big is the Neurofeedback Systems Market?
The Neurofeedback Systems Market size is expected to reach USD 1.30 billion in 2024 and grow at a CAGR of 7.72% to reach USD 1.9 billion by 2029.
What is the current Neurofeedback Systems Market size?
In 2024, the Neurofeedback Systems Market size is expected to reach USD 1.30 billion.